BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 28300812)

  • 21. ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women.
    Isakova J; Vinnikov D; Bukuev N; Talaibekova E; Aldasheva N
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1057-1062. PubMed ID: 31030474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes.
    Kleinjan M; Engels RC; DiFranza JR
    BMC Pulm Med; 2015 Oct; 15():115. PubMed ID: 26449981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between opioid and dopamine receptor gene polymorphisms OPRM1 rs1799971, DAT VNTR 9-10 repeat allele, DRD1 rs4532 and DRD2 rs1799732 and alcohol dependence: an ethnicity oriented meta-analysis.
    Suresh N; Kantipudi SJ; Ramu D; Muniratnam SK; Venkatesan V
    Pharmacogenet Genomics; 2023 Sep; 33(7):139-152. PubMed ID: 37466123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.
    Ray LA; Bujarski S; Squeglia LM; Ashenhurst JR; Anton RF
    Alcohol Alcohol; 2014; 49(3):261-70. PubMed ID: 24421289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.
    Hartwell EE; Feinn R; Morris PE; Gelernter J; Krystal J; Arias AJ; Hoffman M; Petrakis I; Gueorguieva R; Schacht JP; Oslin D; Anton RF; Kranzler HR
    Addiction; 2020 Aug; 115(8):1426-1437. PubMed ID: 31961981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial.
    Schacht JP; Hoffman M; Chen BH; Anton RF
    Pharmacogenomics J; 2022 Feb; 22(1):1-8. PubMed ID: 34381173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.
    Schacht JP; Voronin KE; Randall PK; Anton RF
    Neuropsychopharmacology; 2018 May; 43(6):1247-1256. PubMed ID: 29362512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Translational medicine in Russian cardiology: a new stage or repetition of the past?].
    Tereshchenko SN; Zhirov IV; Kochetov AG
    Ter Arkh; 2016; 88(9):5-9. PubMed ID: 27735907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes.
    Carpentier PJ; Arias Vasquez A; Hoogman M; Onnink M; Kan CC; Kooij JJ; Makkinje R; Iskandar S; Kiemeney LA; de Jong CA; Franke B; Buitelaar JK
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):448-57. PubMed ID: 22841130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.
    Wang XS; Song HB; Chen S; Zhang W; Liu JQ; Huang C; Wang HR; Chen Y; Chu Q
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):752-758. PubMed ID: 26489634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The opioid receptor mu 1 (OPRM1) rs1799971 and catechol-O-methyltransferase (COMT) rs4680 as genetic markers for placebo analgesia.
    Aslaksen PM; Forsberg JT; Gjerstad J
    Pain; 2018 Dec; 159(12):2585-2592. PubMed ID: 30130297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OPRM1 and COMT Gene-Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma.
    Khalil H; Sereika SM; Dai F; Alexander S; Conley Y; Gruen G; Meng L; Siska P; Tarkin I; Henker R
    Biol Res Nurs; 2017 Mar; 19(2):170-179. PubMed ID: 27903758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.
    Ooteman W; Naassila M; Koeter MW; Verheul R; Schippers GM; Houchi H; Daoust M; van den Brink W
    Addict Biol; 2009 Jul; 14(3):328-37. PubMed ID: 19523047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
    Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
    J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emotional Intelligence in Carriers of Different СОМТ, BDNF, DRD2 and HTR2A Genotypes.
    Vorobyeva EV; Kovsh EM; Kosonogov VV
    Psychol Russ; 2022; 15(2):83-96. PubMed ID: 36699706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
    Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
    Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.
    Taheri N; Pirboveiri R; Sayyah M; Bijanzadeh M; Ghandil P
    BMC Psychiatry; 2023 Oct; 23(1):781. PubMed ID: 37880658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.